Skip to main content
. 2016 Sep 9;8:117–125. doi: 10.2147/CPAA.S111867

Table 3.

ΔQTcF by cohort and time

Time (hours) Placebo 3 mg 6 mg 9 mg 12 mg 15 mg
0 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 0)
1.5 −1 (−7.67, 3.33) 3.7 (−16.33, 4) −0.7 (−8.33, 5.33) −3 (−11.33, 1.33) −0.3 (−9.67, 5) 3.3 (−3.33, 8.67)
2 −1.7 −12.67, 7.33) 0.8 (−14.33, 4.33) −1.3 (−9.67, 7) −3.2 (−7.67, 1.67) 0.3 (−7.33, 4.67) 3.3 (−1.33, 6)
3 1.3 (−10, 9) −1.7 (−9.33, 3) −4 (−10, 3) −5.2 (−10.33, 5.33) −0.5 (−6.67, 6) 1.2 (−2, 6.33)
4 0.7 (−13, 8) −1.3 (−11.33, 5.33) −0.7 (−6.33, 3) −2.8 (−10, −1.33) −0.5 (−7, 8.67) −1.3 (−6.67, 3)
8 −6.5 (−19, 4.67) −6.5 (−15.33, 4.33) −7.2 (−19.67, −2) −12.3 (−26, −2) −5.3 (−21.67, 6) −5 (−14.67, 16.67)

Note: Median (min, max) is presented.

Abbreviations: QTcF, corrected QT by Fridericia correction formula; ΔQTcF, change-from-baseline of QTcF.